Tag: Antipsychotics
Adding Antipsychotics Worsens Outcomes in Psychotic Depression
Outcomes were worse for all, with young people on combination therapy twice as likely to experience rehospitalization or death by suicide than those on antidepressants alone.
Cancer Risk Higher for Those on Clozapine
The antipsychotic clozapine, considered the “gold-standard” treatment for psychosis, was found to increase the risk of blood and lymph system cancers.
Industry Corruption in Systematic Review for Injectable Antipsychotics
Researchers highlight how systematic reviews are compromised by pharmaceutical industry ties by exposing a study of injectable antipsychotics.
The New York Times Comments Section: A Literary Rorschach Test for...
Bergner’s piece in The New York Times challenged the illusions of psychiatry. That made some people angry, outraged, or scared. The result is their comments section.
Antipsychotics Often Prescribed Without Informed Consent
New research reveals that patients are often not given fully informed consent before being prescribed antipsychotics.
Antipsychotics Worsen Cognitive Functioning in First-Episode Psychosis
Withholding antipsychotics may be beneficial for memory, the researchers write.
Manufacturer of Tardive Dyskinesia (TD) Drugs Finds TD Emotionally Devastating
“Patients expressed feeling unaccepted by society or uncomfortable in their own skin… A few indicated that they would rather be dead than have tardive dyskinesia.”
Antipsychotics Linked to Increased Breast Cancer Risk
Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.
New Rating Tool for Tapering Antidepressants and Antipsychotics
Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.
Antipsychotics Increase Risk of Dementia; New Research Illuminates Why
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.
Tapered Antipsychotic Withdrawal Mitigates Risk of Psychotic Symptoms
Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.
Barriers to Shared Decision Making in the Prescription of Antipsychotics
Researchers push for a renewed focus on true shared decision-making for patients diagnosed with psychosis.
Minimal Medication Alternatives for Psychosis Needed
Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.
Mental Health Survival Kit, Chapter 2: Is Psychiatry Evidence Based? (Part...
It requires extraordinary mental gymnastics by psychiatrists to conclude that neuroleptics, which cause obesity, metabolic dysfunction, diabetes, tardive dyskinesia, lethal cardiac arrhythmias, and so on, protect against death.
The BBC, Harrow, and a Public Left in the Dark
The recent report by the BBC on medication-free treatment in Norway, when viewed in conjunction with the media silence on Martin Harrow's latest publication, reveals why the public remains misinformed about the long-term effects of antipsychotics.
Recovery Rate Six Times Higher For Those Who Stop Antipsychotics Within...
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.
Exploring Psychiatric Drug Withdrawal: A Town Hall Discussion Series
Our new discussion series aims to explore what we do and don’t know about safe withdrawal from antidepressants, antipsychotics, benzodiazepines and stimulants.
A Short History of Tardive Dyskinesia: 65 Years of Drug-Induced Brain...
Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.
The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia
The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.
Antipsychotic Augmentation Increases Risk of Death
A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.
Very Slow Taper Best for Antipsychotic Discontinuation
An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.
Deep Sleep “Therapy” in Australia in the 1960s & ’70s: Could...
Psychiatry has a history of continuing to perform harmful, even deadly procedures. But does it still happen? Medication-induced akathisia filled two and a half pages of the DSM-IV. Why was it written out of the DSM 5?
Antipsychotics Associated with Severe COVID-19 and Fatal Outcomes
A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.
For People “At Risk for Psychosis,” Antipsychotics Associated with Worse Outcomes
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.
Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.